UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction

Cell death & disease, 2013-05, Vol.4 (5), p.e620-e620

2013

Volltextzugriff (PDF)

Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer

Journal of clinical oncology, 1998-05, Vol.16 (5), p.1677-1683

1998

Volltextzugriff (PDF)

Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma

Cancer research (Chicago, Ill.), 2000-03, Vol.60 (6), p.1546-1551

2000

Volltextzugriff (PDF)

In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients

European Journal of Nuclear Medicine, 1997-02, Vol.24 (2), p.150-159

1997

Volltextzugriff (PDF)

Early vitronectin receptor downregulation in a melanoma cell line during all-trans retinoic acid-induced apoptosis

British journal of dermatology (1951), 2003-03, Vol.148 (3), p.424-433

2003

Volltextzugriff (PDF)

Fractional Retention of Technetium-99m-Sestamibi as an Index of P-Glycoprotein Expression in Untreated Breast Cancer Patients

The Journal of nuclear medicine (1978), 1997-09, Vol.38 (9), p.1348-1351

1997

Volltextzugriff (PDF)

The Cleavage of the Urokinase Receptor Regulates Its Multiple Functions

The Journal of biological chemistry, 2002-12, Vol.277 (49), p.46932-46939

2002

Volltextzugriff (PDF)

The soluble form of urokinase receptor promotes angiogenesis through its Ser88‐Arg‐Ser‐Arg‐Tyr92 chemotactic sequence

Journal of thrombosis and haemostasis, 2010-12, Vol.8 (12), p.2789-2799

2010

Volltextzugriff (PDF)

Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats

Circulation (New York, N.Y.), 2001-06, Vol.103 (24), p.2980-2986

2001

Volltextzugriff (PDF)

Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography : comparison with urokinase levels

Cancer research (Chicago, Ill.), 1993-07, Vol.53 (13), p.3198-3206

1993

Volltextzugriff (PDF)

Vitronectin binding to urokinase receptor in human breast cancer

Clinical cancer research, 1997-08, Vol.3 (8), p.1299-1308

1997

Volltextzugriff (PDF)

Local Concentration of Folate Binding Protein GP38 in Sections of Human Ovarian Carcinoma by In Vitro Quantitative Autoradiography

The Journal of nuclear medicine (1978), 1996-04, Vol.37 (4), p.665-672

1996

Volltextzugriff (PDF)

Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies

Cancer research (Chicago, Ill.), 1994-10, Vol.54 (20), p.5445-5454

1994

Volltextzugriff (PDF)

Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence

The EMBO journal, 1999-06, Vol.18 (11), p.3013-3023

1999

Volltextzugriff (PDF)

Sorafenib-Loaded PLGA Carriers for Enhanced Drug Delivery and Cellular Uptake in Liver Cancer Cells

International journal of nanomedicine, 2023-01, Vol.18, p.4121-4142

2023

Volltextzugriff (PDF)

Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue

Journal of clinical pathology, 1984-01, Vol.37 (1), p.51-55

1984

Volltextzugriff (PDF)

The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis

Thrombosis and haemostasis, 2005-02, Vol.93 (2), p.205-211

2005

Volltextzugriff (PDF)

Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization

Blood, 2005-03, Vol.105 (5), p.2198-2205

2005

Volltextzugriff (PDF)

Cross-talk between fMLP and Vitronectin Receptors Triggered by Urokinase Receptor-derived SRSRY Peptide

The Journal of biological chemistry, 2005-07, Vol.280 (26), p.25225-25232

2005

Volltextzugriff (PDF)

TGF- beta 1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133 super(+) A549 cell fraction

Cell death & disease, 2013-05, Vol.4, p.e620-e620

2013

Volltextzugriff (PDF)

In vitro receptor imaging for characterization of human solid tumors

Nuclear Medicine and Biology [NUCL. MED. BIOL.]. Vol. 21, no. 5. 1994, 1994-07, Vol.21 (5), p.771-774

1994

Volltextzugriff (PDF)

Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells

Journal of cellular physiology, 2004-01, Vol.198 (1), p.31-39

2004

Volltextzugriff (PDF)

TGF-[beta]1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction

Cell death & disease, 2013-05, Vol.4, p.e620

2013

Volltextzugriff (PDF)

Ki-67 and B72.3 expression in breast cancer: an immunohistochemical study

International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology, 1991, Vol.18 (1), p.95,99-97,99

1991

Volltextzugriff (PDF)

Urokinase receptor-dependent and -independent p56/59 super(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence

The EMBO journal, 1999-06, Vol.18 (11), p.3013-3023

1999

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(80)

Publikationsform

Sprache

Englisch
(89)
Italienisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(56)
Life Sciences & Biomedicine
(54)
Humans
(47)
Female
(30)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Adult
(22)
Middle Aged
(21)
Animals
(13)
Male
(13)
Aged
(12)
Receptors, Urokinase Plasminogen Activator
(12)
Tumors
(11)
Gynecology. Andrology. Obstetrics
(10)
Reduction Of Gas Emissions
(10)
Motor Vehicle
(9)
Motor Vehicle Pollution
(9)
Oncology
(9)
Technical Standard
(9)
Combustion Gases
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction

Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer

Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma

In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients

Early vitronectin receptor downregulation in a melanoma cell line during all-trans retinoic acid-induced apoptosis

Fractional Retention of Technetium-99m-Sestamibi as an Index of P-Glycoprotein Expression in Untreated Breast Cancer Patients

The Cleavage of the Urokinase Receptor Regulates Its Multiple Functions

The soluble form of urokinase receptor promotes angiogenesis through its Ser88‐Arg‐Ser‐Arg‐Tyr92 chemotactic sequence

Effects of balloon injury on neointimal hyperplasia in streptozotocin-induced diabetes and in hyperinsulinemic nondiabetic pancreatic islet-transplanted rats

Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography : comparison with urokinase levels

Vitronectin binding to urokinase receptor in human breast cancer

Local Concentration of Folate Binding Protein GP38 in Sections of Human Ovarian Carcinoma by In Vitro Quantitative Autoradiography

Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies

Urokinase receptor-dependent and -independent p56/59(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence

Sorafenib-Loaded PLGA Carriers for Enhanced Drug Delivery and Cellular Uptake in Liver Cancer Cells

Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue

The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis

Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization

Cross-talk between fMLP and Vitronectin Receptors Triggered by Urokinase Receptor-derived SRSRY Peptide

TGF- beta 1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133 super(+) A549 cell fraction

In vitro receptor imaging for characterization of human solid tumors

Cripto-1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF-7 breast cancer cells

TGF-[beta]1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 cell fraction

Ki-67 and B72.3 expression in breast cancer: an immunohistochemical study

Urokinase receptor-dependent and -independent p56/59 super(hck) activation state is a molecular switch between myelomonocytic cell motility and adherence

Suchergebnisse filtern